Research Article
Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage
Table 1
Study group patients’ characteristic.
| | Male | 15 (56%) | | Age (years) | 58.07 ± 15.8 |
| | Aneurysm location |
| | Middle cerebral artery | 7 (26%) | | Anterior communicating artery | 7 (26%) | | Anterior cerebral artery | 4 (15%) | | Basilar artery | 4 (15%) | | Internal carotid artery | 3 (11%) | | Posterior cerebral artery | 2 (7%) |
| | Aneurysmal size (mm) | 5.08 ± 1.8 | | Cerebral infarction due to DCI on CT | 20 (74%) | | Intracerebral haemorrhage on CT | 14 (52%) | | Intraventricular blood on CT | 26 (96%) | | Fisher CT score | 4 (4-4) | | Modified Fisher CT score | 4 (2–4) | | WFNS score on admission | 5 (3–5) | | HH score on admission | 4 (4-5) | | GCS on admission | 5 (4–10) |
| | | Post-SAH days 0–3 | Post-SAH days 5–7 | Post-SAH days 10–14 |
| | CRP level (mg/L) | 106.90 ± 88.9 | 129.68 ± 96.8 | 75.09 ± 84.3 | | WBC count (106/mm3) | 13.81 ± 5,4 | 12.01 ± 5.0 | 14.35 ± 6.3 | | Hgb level (mg/dL) | 12.52 ± 1.7 | 12.10 ± 1.6 | 10.84 ± 1.2 | | Fibrinogen (mg/dL) | 415.61 ± 163.0 | 617.63 ± 241.1 | 600.33 ± 247.7 | | sRAGE (pg/mL) | 3.91 ± 4.0 | 4.24 ± 3.9 | 4.05 ± 3.8 |
| | Treatment outcome (according to GOS at 3 months) |
| | Low disability (score of 5) | 5 (19%) | | Moderate disability (score of 4) | 2 (7%) | | Severe disability (score of 3) | 4 (15%) | | Persistent vegetative state (score of 2) | 5 (19%) | | Death (score of 1) | 11 (41%) |
|
|
